FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 180 filers reported holding FATE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,064,941 | -54.4% | 2,389,123 | +2.3% | 0.03% | -53.1% |
| Q2 2023 | $11,115,162 | +45.1% | 2,335,118 | +73.8% | 0.06% | +36.2% |
| Q1 2023 | $7,658,685 | +11682.6% | 1,343,629 | +8143.1% | 0.05% | +4600.0% |
| Q3 2017 | $65,000 | -59.9% | 16,300 | -67.4% | 0.00% | -66.7% |
| Q2 2017 | $162,000 | -41.3% | 50,004 | -17.6% | 0.00% | -50.0% |
| Q1 2017 | $276,000 | +16.9% | 60,704 | -35.4% | 0.01% | +20.0% |
| Q4 2016 | $236,000 | -39.2% | 93,982 | -24.5% | 0.01% | -28.6% |
| Q3 2016 | $388,000 | +27.6% | 124,472 | -30.3% | 0.01% | +16.7% |
| Q2 2016 | $304,000 | -17.4% | 178,647 | -12.6% | 0.01% | -25.0% |
| Q1 2016 | $368,000 | +192.1% | 204,447 | +448.8% | 0.01% | +166.7% |
| Q4 2015 | $126,000 | – | 37,253 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |